PET partners target new centers

Article

InHealth Group and CTI have agreed to jointly develop seven new PET and PET/CT centers in the U.K. and to collaborate in the management of existing InHealth imaging centers to provide PET and PET/CT services. Onsite manufacturing facilities using CTI

InHealth Group and CTI have agreed to jointly develop seven new PET and PET/CT centers in the U.K. and to collaborate in the management of existing InHealth imaging centers to provide PET and PET/CT services. Onsite manufacturing facilities using CTI technology will produce positron radioisotopes, including FDG. The new centers will be established in close collaboration with the U.K.'s major National Health Service trusts and leading academic institutions. Additionally, the two companies will support a U.K.-wide mobile scanning service. Both the mobile service and the first scanning center are already operational, and InHealth has already carried out more than 2000 PET scans. InHealth will utilize CTI's cyclotron and chemistry technology and expertise in the development of new PET tracer production, pharmacy, and distribution facilities.

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.